Evotec and Cyprotex are exhibiting and presenting at this event. Visit us at our booth #B20 to engage with our scientific experts, or join our scientific contributions per the below.
Evotec at ELRIG Drug Discovery 2024
Industry Insider Presentation: Automated High Content Screening – Cell Painting to Accelerate Drug Discovery through Data
Date and Time: Thursday, 3rd October; 12:15 – 12:30; within track "Robotics, Automation, Data and AI: Driving Innovations and Key Applications in Drug Discovery"
Location: Tech Theatre
Evotec applies a variety of high content screening approaches to support drug discovery programs. Amongst them, high content imaging technology allows to identify effects of small molecules on multiple cellular processes. With state-of-the-art automated platforms, robotics, reader systems and sophisticated workflows we enable highest quality phenotypic screening programs. Beyond classical phenotypic screening, morphological profiling of cell populations has gained attention in high content imaging. This process is called Cell Painting and is applicable throughout the drug discovery process. It includes phenotype characterization, hit identification, target deconvolution, early prediction of compound mode-of-action as well as early safety/tox assessment. The generated high dimensional data packages are the basis for advanced data science and AI/ML predictions used for optimized hit selection. The presentation will outline the data processing steps, examples of the usage in the drug discovery phase and an entry into predictive data.
Presented by Sven Schreiter, Senior Research Scientist
Advances in Assay Development and Screening track
co-chaired by Saman Honarnejad, Business Development Director
